AMRI CEO to Present at the 2013 Wells Fargo Securities Healthcare Conference PR Newswire ALBANY, N.Y., June 12, 2013 ALBANY, N.Y., June 12, 2013 /PRNewswire/ --AMRI (NASDAQ: AMRI) announced today that Thomas E. D'Ambra, Ph.D., President and Chief Executive Officer at AMRI, will present at the 2013 Wells Fargo Securities Healthcare Conference on Wednesday, June 19, 2013 at 10:40 a.m. ET. (Logo: http://photos.prnewswire.com/prnh/20120229/NY61160LOGO ) About AMRI Albany Molecular Research, Inc. (AMRI) is a global contract research and manufacturing organization offering customers fully integrated drug discovery, development and manufacturing services. For over 21 years, AMRI has demonstrated its adaptability as the pharmaceutical and biotechnology industries have undergone tremendous change in response to multiple challenges. This experience, a track record of success and locations in the United States, Europe and Asia now provides our customers with SMARTSOURCING™, a full range of value-added opportunities providing customers informed decision-making, enhanced efficiency and more successful outcomes at all stages of the pipeline. AMRI has also successfully partnered R&D programs and is actively seeking to out-license its remaining programs for further development. For more information about AMRI, please visit our website at www.amriglobal.com or follow us on Twitter (@amriglobal). SOURCE AMRI Website: http://www.amriglobal.com Contact: Investors - Michael Nolan, AMRI Chief Financial Officer, 518-512-2261; Media - Gina Monari, AMRI Communications, 518-512-2512
Alibaba Indicated to Start Trading at $84 to $87
AMRI CEO to Present at the 2013 Wells Fargo Securities Healthcare Conference
Press spacebar to pause and continue. Press esc to stop.